VIA
ONC

Virtus Investment Advisers’s BeOne Medicines Ltd ONC Stock Holding History

Virtus Investment Advisers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$786K Buy
2,646
+505
+24% +$163K 0.22% 164
2025
Q4 		$650K Buy
2,141
+534
+33% +$175K 0.18% 203
2025
Q3 		$548K Hold
1,607
– – 0.16% 194
2025
Q2 		$389K Sell
1,607
-382
-19% -$93.7K 0.13% 229
2025
Q1 		$541K Buy
+1,989
New +$465K 0.15% 196

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Virtus Investment Advisers's ONC Position: Q1 2026 in Review

Virtus Investment Advisers increased its BeOne Medicines Ltd (ONC) stake by 24% in Q1 2026, buying an estimated $163K and bringing the position to 2,646 shares worth $786K. The position accounts for 0.22% of the portfolio, ranked #164.

Virtus Investment Advisers first reported a position in ONC in Q1 2025 and has held it in 5 quarters since. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Virtus Investment Advisers held 2,646 shares of BeOne Medicines Ltd worth $786K as of Q1 2026.
  • Virtus Investment Advisers bought 505 BeOne Medicines Ltd shares in Q1 2026, an estimated $163K.
  • BeOne Medicines Ltd made up 0.22% of Virtus Investment Advisers's portfolio in Q1 2026, its #164 holding.
  • Virtus Investment Advisers first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 5 quarters since.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.